# Psychedelics Stock, Up 190% This Year, Flies High Again

> **Open Intelligence Dossier** · First detected: 2026-09-15 08:23 UTC · Category: Business

## Executive Summary
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Psychedelics Stock, Up 190% This Year, Flies High Again" is generating significant coverage in the Business category, with 12 articles from 11 distinct sources tracked by PULSE so far.


Outlets currently covering the story include AllSci, TipRanks, Yahoo Finance and Dealroom. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| AllSci | Definium’s LSD therapy posts second positive Phase III GAD result | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxOZ2ZXVkU3RWtfWVZZa0MwNXU2VGtkNUZDRkkxR1I3blRkX1RYOXNsZURDNXdhcWhZRzdKdFgzSHFZSzI2R1pqT2xWV19xelQ5cEZqSm9tNEFPWHBneTItMS1mU2ROa1dobjRYNGZrcEhBVlRNYXdJdmdJUlVJT2Q1OGt5Sjloemc?oc=5) |
| TipRanks | Definium Therapeutics price target raised to $75 from $70 at Oppenheimer | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxPMjMyM1A0OUkzQ1dQZW9fRWwwbDNyUW9oUlZyY3lTLUtPb3BZVXhYenhuUW56VXA4cmlodWVtdTFpZ0l5TzNTQVhIUDM0Q3B4bmJTN0p1S1czc1ZLcm1Jb25hV2V3ZnltMXRoa2VQeFNjakZva2NQVThFM0QtR3RCeXBTNXBYZnJNbkpnaU01azI0Z0lnQklLYTNhZlQ5NllwcWNfLWtZaG1fUW1rZVh5am9vdXJrMGZJdkJVQg?oc=5) |
| Yahoo Finance | Definium Reports Second Phase III Success in Anxiety Disorder Program | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxNRy1PcEVjUVo4ckhRWGZyOFhObEo1SGVsbFI5Q1JyREhFdHk2SUxnSFpNV3ptUllNY09nRGp1dDlOU0pMZ2c0Zk5EenljdnlZLUZwaXc2NGVxeXpEYlUzZGFFcWpBMWxteHVZSmtHbGRiQ2I4UGlWSzVQLTdUQVRMRHhqcDFTR2xlNjQ5UUhRbU0wdEJhTVNOb3Z3?oc=5) |
| Dealroom | Definium Therapeutics notches third straight Phase 3 win as DT120 psychedelic hits goals in generalised anxiety disorder | [Source Link](https://news.google.com/rss/articles/CBMi6gFBVV95cUxOV0dCOS1tWHNic0lFUjFzRVNDZGh4dWJ2Ny1NM2FDOXBSQ3pVYjUyUFJzWE9aS0NPZmh1Snh5NmVrdTZsYnM4Y0hldVc2cGU0eUtIU2stSy1SdkRLdXIyMjJxcjBSTlIzbzBTVEI2U3duRS1RMHNmRzVoTkI4Tks1YnczOENHM1MtcXU1MkJGUF9nOEZLeWt3NnJpWlk5WURyUnRtcVM1ekRWVGpGUDNhNVRCMUJpMU5heU9zODhiYUNxTVlDWTBENjc3dXVKQzRPTm1qMV96Z2hFOThCRm5HdmZnT25qSXZrdWc?oc=5) |
| GuruFocus | DFTX Maintained by Baird -- Price Target Raised to $79.00 | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNaHdNaHJZYjFQTS1EbDY4VWpfTU1zZl9DWVZLQlVROHRLa1JxTjAzMGpuSlZEbWlDZVJBamJqVHJFR2o5ZjliV3V3Q1JpejVRa3JDUHNRdDA2Q3pOZzNTR0xYanNuN2oySTQwQ2s1Ung1RXpkc29nbWl0V0laVEh4VFFJUG84M0d4aHAtaGp3LVcwanRhLXc?oc=5) |
| Business Wire | Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder | [Source Link](https://news.google.com/rss/articles/CBMilAJBVV95cUxOZWdiQkVYUzJzak5DNVpaR3RXSklEVW5tY01GR2FuSVNzQUdDLUd3U0ZiR3l0VW1ULU1yWmd5eDZEZEk1eTNLclA2NEIxdWx2RDF6N3U4RWZna2ZkRmRDU2czdFJHc3RpNlpxWU02TlhvYkkxWnd5aEdhTUlIUi14QVl1eHdXMno5SVNELVJMVmhJUU05eWVzWW40b05BTVVLeGZ5cnN4YkIyQU1hV0NXZUMycVZkeVYyRWxSaVZUdDE4cVU5NFVLQ2dGbGFaR0FqSGRkYktJMzctdUJqOGxpTVlmcHhTZlZRM0Jqd0h4MHlGcVFZc1JPQ3JoTzRtVlo1WVBHUzhPVXdOMmR3enBGOVJSUzQ?oc=5) |
| BioSpace | Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’ | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxPM3JmTVhyVjdIejBONE1lRHZwNHA5OHhaM0M3U21VdzlFYUs5V3VDUnN1YmZ0WFVzb0xWQTZrZUt1T0taZEFudldkbE8tclVYVkVUcFdfSEgzRWhMeFFhOThiYjREQ2hZV0Fud3JhSmNUc0JxSWVxc28tS1ZCcGpRaDRsNzgwbjV4cEdNd1RsQ0tRdzNFUGEwS0JaV2dHcWNSdEdLS0Q2ajZDbzNGanJQRm9RTldCYTQteGw0bW1WWldkcDcw?oc=5) |
| STAT | Definium’s LSD therapy eased anxiety in second large trial | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNa205MHAyM04wZFlUS1dOYUcxSGdDM2FFRVcxTVdybmNUQjdHd2RmOEt2dTF1RXpud3E0RHl0cnhzVEY0cS13U2JQN1lJakY1RFhhU1RKVWFoTU1KRUREU2xGR2tJR3lDbENaME55RF82dnl4RlB1WE1Ga0dlZXl3bk9uaDBYcWFTbjVsazZPZ3BFWmVSYi1sRzhBa0Y?oc=5) |
| FirstWord Pharma | Definium's psychedelic notches another Phase III win in anxiety | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWQ2xPM0RCc2pEaHNpRklmZnBia1JCNWZTNi1CYlBnRHUyb0dxVFg5cC1IdFZsRmFBODB1cTM3WExjekY0MjRWbnVfYWdld1dONmFJ?oc=5) |
| Yahoo Finance | Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxPQlUwUk91QlU1MUMtdmk0WVBVNFdlNlpOMHFTc0JNTlpBZ0NnY1pyTlpKNGdxbllHM2o3ejB6VlFJYmVHRTNzUVE3dVA5Q3VjcENUaDlDM2t3LVNnRGNRdktpZzhtVkRfbTZtZlBsYXhWMFhLZEpHNjhXajZjZVplYWJLcllhUlJxRkNzS1Y2d1ZmWEJ5N2d0cjN3M2pSSFBYMXUtbDZCV2dzMkVnSHc?oc=5) |
| Reuters | Definium's LSD-based anxiety, depression drug scores another trial win | [Source Link](https://news.google.com/rss/articles/CBMi3wFBVV95cUxNWHNUYU9wTUxWWTdITnNZc0l3dnJsdlZCZ29uOE5RVWc3QWpmUmZ2RW83UHpfNUdxby13T0FPSHNqQkhud0xmMm4tWnZpaTNacHZHMzdFUFZXSDczM0dUNTRJdE1xc2RZQ19vTTA3anJmUl8xSXhoWk5PazJvSXFKdmdFUWlvNHJQdnBDd0VYLTVHUzJpOGpfTTczNzJOakdhd2QxNl9WMWwyVmpuYjI4ZGp4NHpvd1RiSTdsbWlETlBlYnJLZWZwYXMycWU5UHVzWHA2ME1sS0g3Zy1JRFdB?oc=5) |
| Investor's Business Daily | Psychedelics Stock, Up 190% This Year, Flies High Again | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdlZoaWJZbGpuek1tVkxVbll0LVNIazZzbFZ0eEdkNFA2RXllSnBaQkdZajdBV29mMGdHRFJjd2pDX2cyS0h1Nm5BRl9rbWZBNk9rUFM5TFRsYUJrZDUtTll5ejVQcUxUanNZczN0ZmpORWxxaXl4NEFUTmZWdkk0SWk5VXVwX2NSWUxMZzRUWDFiWEt6SXFYNjk2bE0yMXFjbDlmcmxuWXQwYnM?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-09-15/psychedelics-stock-up-190-this-year-flies-high-again*